Chattopadhyay et al. [20] found that high expression of SDHA was associated with the risk of metastatic spread and poor clinical outcome in patients with uveal melanoma, and Olszewski et al. found inhibition of tumor growth in a patient-derived xenograft model of SDHA-deficient tumors [21]. This evidence concerns the gene SDHA and uveal melanoma.